Drug Development Archives

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

Case Study

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.

CertaraJuly 29, 2025

On-Demand Webinar

Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling

CertaraJuly 29, 2025

On-Demand Webinar

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.

CertaraJuly 29, 2025

Conference

AusBiotech International Conference 2025

Danielle PillsburyJuly 25, 2025

Blog

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…

CertaraJuly 23, 2025

On-Demand Webinar

Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation

CertaraJuly 18, 2025

Case Study

Accelerating Oncology Drug FDA RTOR Submission with Project Management Services

Discover how Certara’s dedicated project management and pharmacometric support helped an emerging biotech company fast-track…

CertaraJuly 2, 2025

Press Coverage

The Medicine Maker: The Biosimulation Generation

The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…

Danielle PillsburyJuly 1, 2025

Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…

CertaraJune 30, 2025

Drug Development

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

AusBiotech International Conference 2025

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation

Accelerating Oncology Drug FDA RTOR Submission with Project Management Services

The Medicine Maker: The Biosimulation Generation

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Newsletter sign up

Quick links

Solutions

Contact